High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: Application to pharmacokinetics

https://doi.org/10.1016/0378-4347(85)80172-9Get rights and content

Abstract

A selective and very sensitive ion-pairing reversed-phase high-performance liquid chromatographic method has been developed for the simultaneous determination of diltiazem and four of its metabolites in plasma. The structurally related compound propionyl deacetyldiltiazem was used as the internal standard and bromide was employed as the pairing ion. Plasma samples were extracted with methyl-tert.-butyl ether followed by back-extraction into 0.01 M hydrochloric acid and evaporation to dryness. High-performance liquid chromatographic analysis was carried out using C18-bonded silica and methanol—ammonium bromide—acetonitrile—triethylamine as the mobile phase. Using UV detection at 237 nm, the lower limit of detection in plasma was 0.1–0.2 ng/ml; calibration curves were linear between 1 and 800 ng/ml.

The present assay procedure has been applied to monitoring plasma levels in intravenous and oral pharmacokinetic studies in several animal species and humans. The applicability of the new method could be confirmed by comparing plasma levels obtained by high-performance liquid chromatography with those obtained by gas chromatography.

References (17)

  • S.J. Rosenthal et al.

    Am. J. Cardiol.

    (1980)
  • V. Rovei et al.

    J. Chromatogr.

    (1977)
  • R. Calaf et al.

    J. Chromatogr.

    (1983)
  • J.P. Clozel et al.

    J. Pharm. Sci.

    (1984)
  • Ch. Verghese et al.

    J. Chromatogr.

    (1983)
  • R.E. Wiens et al.

    J. Pharm. Sci.

    (1984)
  • J.E. Greving et al.

    J. Chromatogr.

    (1979)
  • A. Wehrli et al.

    J. Chromatogr.

    (1978)
There are more references available in the full text version of this article.

Cited by (71)

  • Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: Possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin

    2011, Pharmacological Reports
    Citation Excerpt :

    The blood samples were centrifuged (13,000 rpm, 3 min ), and a 200-µL aliquot of plasma samples was stored at –40°C until the HPLC analysis. The plasma concentrations of diltiazem were determined using a modified version of the HPLC assay reported by Goebel and Kolle [12]. Briefly, 50 µl of imipramine (2 µg/ml), as the internal standard, and 1.2 ml of tert-butylmethylether was added to 0.2 ml of the plasma sample.

View all citing articles on Scopus
View full text